GW642444

Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics

Condition:   AsthmaInterventions:   Drug: Fluticasone furoate/Vilanterol Inhalation Powder;   Drug: Fluticasone Furoate Inhalation Powder;   Drug: Placebo Inhaltion PowderSponsor:   GlaxoSmithKlineRecruiting – verified October 2010 View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days

QTc Study With Flucticasone Furoate & GW642444

Conditions:   Asthma;   Chronic Obstructive Pulmonary DiseaseInterventions:   Drug: Fluticasone furoate (200 mcg)/GW642444 (25mcg) combination;   Drug: Fluticasone furoate (400 mcg)/GW642444 (50mcg) combination;   Drug: Placebo Inhaler;   Drug: Moxifloxacin 400mg;   Drug: Moxifloxacin placeboSponsor:   GlaxoSmithKlineRecruiting – verified September 2010 View full post on ClinicalTrials.gov: “Asthma” |…